{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2021"],"data_sharing_plan":["IPD Sharing (as of November 2022): Undecided\nDescription: Individual participant data that underline the results reported in publications of the study may be shared after de-identification. This may include text, tables, figures, and appendices. The study protocol, statistical analysis plan, and informed consent form will also be shared. Data may be shared with researchers who provide a methodologically sound proposal to achieve the aims outlined in the approved proposal."],"condition":["Stomach Cancer","Kidney Neoplasms","Lung Cancer","Head and Neck Cancer","Colorectal Cancer","Bladder Cancer","Liver Cancer","Lung Neoplasms","Pancreas Cancer","Esophageal Cancer","Kidney Cancer","Stomach Neoplasms","Pancreatic Neoplasms"],"disease":["Stomach Cancer","Kidney Neoplasms","Lung Cancer","Colorectal Cancer","Liver Cancer","Bladder Cancer","Lung Neoplasms","Pancreas Cancer","Esophageal Cancer","Head And Neck Cancer","Kidney Cancer","Pancreatic Neoplasms","Stomach Neoplasms"],"study_type":["Observational"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2372841"],"location":["United States"],"study_start_month":["3"],"repository":["ECRIN MDR"],"study_status":["Recruiting"],"additional_accession":[]},"is_claimable":false,"name":"DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)","description":"The primary objective of this study, DELFI-L101, is to train and test classifiers for lung cancer detection using the DELFI assay and other biomarker and clinical features.","dates":{"creation":"2021-03-15"},"accession":"2372841","cross_references":{"ClinicalTrials___gov":["NCT04825834"]}}